Left Breast Plan Above the Cardiac Constraint: Is DIBH the Right Answer?
Mrs. L, 54, has stage I left breast cancer after lumpectomy and will receive whole-breast 42.56 Gy/16 fractions plus a 10.64 Gy/4-fraction boost. The free-breathing planning CT gives a mean heart dose of 7.9 Gy and LAD V2Gy of 62%. Your department's left-breast planning goals are mean heart dose <4 Gy and LAD V2Gy <10%. Two DIBH coaching scans show 6 mm variation in chest-wall position and 4 mm in heart position between holds; she can hold her breath 18 seconds and has no cardiac history. She asks whether breath-hold "will keep the radiation off my heart."
1. Do the data support proceeding with DIBH for this patient? What else must be checked before committing?
Read the worked answer
The free-breathing plan fails both goals, so change is justified; the question is whether DIBH is reliable enough. Reproducibility of 6 mm chest wall/4 mm heart across two coaching scans is marginal for a gated technique - DIBH only helps if the daily position matches the planning position. Before committing, check:
- Whether the DIBH scan actually meets the goals - a DIBH plan can still fail if the heart moves into the tangent fields; calculate it, don't assume.
- Whether the 18-second hold covers the beam-on time, including imaging and boost fields; if beam-on exceeds the hold, you get drift.
- Whether she can reproduce the hold on the treatment couch (different from the CT couch) with visual coaching and a spirometer/ABC or surface guidance.
- Whether daily image guidance can verify the breath-hold position (e.g., surface imaging or daily CBCT in breath-hold).
If DIBH is not reproducible, alternatives exist: prone positioning, intensity-modulated/proton techniques, or a modest re-plan with more medial/lateral weighting - all of which must be re-evaluated against the same cardiac goals.
2. When you evaluate the DIBH plan, which dosimetric endpoints actually matter, and what would you reject?
Read the worked answer
Don't judge on mean heart dose alone. For left breast, evaluate:
- Heart: mean dose, V25 Gy (or the hypofractionated equivalent), and V5 Gy.
- LAD: mean dose and V2 Gy/V10 Gy - the LAD is the structure most tightly linked to late cardiac injury and is often the structure that fails even when heart mean dose is acceptable.
- Lungs: ipsilateral lung V20 Gy and mean dose (pneumonitis risk, especially with any regional nodal coverage).
- Target coverage and homogeneity: whole breast V95% ≥95–98% per protocol, and hotspot limits; a cardiac-sparing plan that underdoses the lower breast is not acceptable.
- Contralateral breast and skin dose.
Reject a plan that meets heart mean dose by carving coverage out of the target, or one where the LAD dose is still high despite a low heart mean. Compare the DIBH and free-breathing plans side by side and document both.
3. How do you answer her question, and what must be verified daily on the machine?
Read the worked answer
Answer honestly and in plain terms: breath-hold lowers the dose to the heart and the LAD substantially compared with free breathing, but it does not eliminate cardiac dose, and the benefit depends on her holding her breath the same way every day - which is why you coached and scanned her twice. Frame it as risk reduction, not zero risk, and note that her age and absence of cardiac history make the absolute benefit modest but real over decades.
Daily on the machine: verify the breath-hold level with the same surrogate used at CT (surface imaging, spirometer, or video coaching), take imaging in the treatment breath-hold, and treat only within the hold window. Watch for drift, cough, or a short hold - release and re-coach rather than treat through it. Document hold reproducibility each day, and plan to repeat imaging/CT if her holds degrade or her weight changes.